15-45108159-C-T
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PP5_Very_Strong
The ENST00000389039.11(DUOX2):c.1462G>A(p.Gly488Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,614,132 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.00025 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000095 ( 0 hom. )
Consequence
DUOX2
ENST00000389039.11 missense
ENST00000389039.11 missense
Scores
10
7
2
Clinical Significance
Conservation
PhyloP100: 7.39
Genes affected
DUOX2 (HGNC:13273): (dual oxidase 2) The protein encoded by this gene is a glycoprotein and a member of the NADPH oxidase family. The synthesis of thyroid hormone is catalyzed by a protein complex located at the apical membrane of thyroid follicular cells. This complex contains an iodide transporter, thyroperoxidase, and a peroxide generating system that includes this encoded protein and DUOX1. This protein is known as dual oxidase because it has both a peroxidase homology domain and a gp91phox domain. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PP5
Variant 15-45108159-C-T is Pathogenic according to our data. Variant chr15-45108159-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 225342.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DUOX2 | NM_001363711.2 | c.1462G>A | p.Gly488Arg | missense_variant | 13/34 | ENST00000389039.11 | NP_001350640.1 | |
DUOX2 | NM_014080.5 | c.1462G>A | p.Gly488Arg | missense_variant | 13/34 | NP_054799.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DUOX2 | ENST00000389039.11 | c.1462G>A | p.Gly488Arg | missense_variant | 13/34 | 1 | NM_001363711.2 | ENSP00000373691 | P4 | |
DUOX2 | ENST00000603300.1 | c.1462G>A | p.Gly488Arg | missense_variant | 13/34 | 1 | ENSP00000475084 | A1 | ||
DUOX2 | ENST00000558383.1 | n.3193G>A | non_coding_transcript_exon_variant | 7/17 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152160Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
38
AN:
152160
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000135 AC: 34AN: 251434Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135904
GnomAD3 exomes
AF:
AC:
34
AN:
251434
Hom.:
AF XY:
AC XY:
19
AN XY:
135904
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000951 AC: 139AN: 1461854Hom.: 0 Cov.: 33 AF XY: 0.0000935 AC XY: 68AN XY: 727234
GnomAD4 exome
AF:
AC:
139
AN:
1461854
Hom.:
Cov.:
33
AF XY:
AC XY:
68
AN XY:
727234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000250 AC: 38AN: 152278Hom.: 0 Cov.: 30 AF XY: 0.000228 AC XY: 17AN XY: 74464
GnomAD4 genome
AF:
AC:
38
AN:
152278
Hom.:
Cov.:
30
AF XY:
AC XY:
17
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
22
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Thyroid dyshormonogenesis 6 Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Aug 15, 2018 | Across a selection of the available literature, the DUOX2 c.1462G>A (p.Gly488Arg) missense variant has been reported in at least 18 unrelated patients with congenital hypothyroidism, including in a homozygous state in two siblings and an unrelated individual, in a compound heterozygous state in at least seven individuals, and in a heterozygous state in nine individuals in whom a second variant in the DUOX2 gene was not identified (Narumi et al. 2011; Yoshizawa-Ogasawara et al. 2013; Jin et al. 2014; Park et al. 2016; Srichomkwun et al. 2017). In several of these cases, the variant was shown to be inherited from an unaffected parent. In addition, one patient with dyshormonogenesis and an enlarged thyroid was heterozygous for the p.Gly488Arg variant and a second missense variant, but phase was not specified (Narumi et al. 2011). The p.Gly488Arg variant was absent from at least 100 alleles and is reported at a frequency of 0.001503 in the East Asian population of the Exome Aggregation Consortium. By assaying hydrogen peroxide production, two independent groups showed the variant protein displays greatly reduced activity compared to the wild type protein in HEK293 and A549 cells (Narumi et al. 2011; Jin et al. 2014). Based on the collective evidence, the p.Gly488Arg variant is classified as pathogenic for congenital hypothyroidism. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Likely pathogenic, criteria provided, single submitter | reference population | Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center | Mar 18, 2016 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 26, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | May 22, 2022 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.015%). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.71; 3Cnet: 0.51). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000225342). The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least 2 similarly affected unrelated individuals (PMID: 21900383, 23457309, 25248169, 26709262). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 24, 2021 | The c.1462G>A (p.G488R) alteration is located in exon 13 (coding exon 12) of the DUOX2 gene. This alteration results from a G to A substitution at nucleotide position 1462, causing the glycine (G) at amino acid position 488 to be replaced by an arginine (R). Based on data from the Genome Aggregation Database (gnomAD) database, the DUOX2 c.1462G>A alteration was observed in 0.015% (42/282816) of total alleles studied, with a frequency of 0.12% (24/19952) in the East Asian subpopulation. This alteration has been detected in multiple individuals with congenital hypothyroidism, in the homozygous state, the compound heterozygous state, and in the heterozygous state without a second alteration identified (Narumi, 2011; Yoshizawa-Ogasawara, 2013; Jin, 2014; Srichomkwun, 2017; Sun, 2018; Abe, 2018; Peters, 2019). This amino acid position is highly conserved in available vertebrate species. A hydrogen peroxide production assay showed significantly decreased hydrogen peroxide compared to wild type protein in HEK293 and A549 cells (Narumi, 2011; Jin, 2014). The in silico prediction for the p.G488R alteration is inconclusive. Based on the available evidence, this alteration is classified as likely pathogenic. - |
DUOX2-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 01, 2023 | The DUOX2 c.1462G>A variant is predicted to result in the amino acid substitution p.Gly488Arg. This variant was reported in individuals with autosomal recessive congenital hypothyroidism and thyroid dyshormonogenesis, with complete loss of function observed in functional in vitro assays (Narumi et al. 2011. PubMed ID: 21900383; Yoshizawa-Ogasawara et al. 2013. PubMed ID: 23457309; Jin et al. 2014. PubMed ID: 25248169). This variant is reported in 0.12% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/15-45400357-C-T) and is reported as likely pathogenic or pathogenic by many outside laboratories in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/225342/). This variant is interpreted as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 02, 2023 | Published functional studies demonstrate a damaging effect as the generation of H2O2 was significantly reduced in the G488R transfected cells (PMID: 25248169, 21900383); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27821020, 34200080, 31044655, 21900383, 26709262, 25248169, 30609409, 29650690, 32469330, 32459320, 29092890, 23457309, 32425884, 34426522, 33631011, 33651715) - |
Nongoitrous Euthyroid Hyperthyrotropinemia Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | Jan 01, 2017 | - - |
Familial thyroid dyshormonogenesis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 14, 2017 | The p.Gly488Arg (NM014080.4 c.1462G>A) variant in DUOX2 has been reported in 9 h eterozygous, 3 homozygous, and 8 compound heterozygous Asian individuals with cl inical features of congenital hypothyroidism and related disorders (Narumi 2011, Yoshizawa-Ogasawara 2013, Jin 2014, Park 2016, Srichomkwun 2017). This variant has been identified in 0.15% (13/8,652) of East Asian chromosomes by the Exome A ggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs191759494). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. In vitro func tional studies provide support that the p.Gly488Arg variant impacts protein func tion (Narumi 2011 and Jin 2015). In summary, this variant meets criteria to be c lassified as pathogenic for congenital hypothyroidism and related disorders in a n autosomal recessive manner based upon biallelic occurrence in affected individ uals, low frequency in control populations, and functional studies. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
T;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
.;H
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.
REVEL
Pathogenic
Sift
Uncertain
D;.
Sift4G
Uncertain
D;D
Polyphen
1.0
.;D
Vest4
MutPred
Gain of methylation at G488 (P = 0.0365);Gain of methylation at G488 (P = 0.0365);
MVP
MPC
0.40
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at